• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
12.04.2024
CarMax Is More Committed to Innovations But Market Conditions Make It Sinking

CarMax (KMX) quarterly report came out on April 11, vividly displaying why any immediate investment into the used car market still sounds like not a good idea. The stock quickly lost ground, wasting a double-digit number of percentage points as a response to its net income drop to $0.32 per share against $0.44 cents per share a year ago, also compared to much stronger $0.52, $0.75 and $1.44 per share in the previous three quarters. Analyst polls estimated a net income per share at about $0.50, which would be 56% better than the reality.

This almost looks like a financial fiasco in the company's efforts to withstand slowing demand in the segment. CarMax Q4 2023 revenue decreased by 1.7% to $5.6 billion, slightly below consensus expectations of $5.8 billion, indicating the lack of gross marginality of the business. This happened even though the total supply of unsold used vehicles on dealer lots grew by 9% YoY to 2.27 million units in March, according to Cox Automotive data. CarMax CEOs delayed their own goal of selling over 2 million units annually, when measuring combined retail and wholesale actions, to between 2026 and 2030, from its prior target of 2026.

A "higher-for-longer" Fed fund rates is demonstrably bad for car sales volumes, be it new generation Tesla cars or just pre-owned vehicles, while operating costs for warehouses are growing. Besides, easing some semiconductor constraints in North America may help marginally improving orders for new cars, leaving used-car sales under the same pressure. Meanwhile, the entrance of Asia players offered significant discounts. Therefore, North American and European operators of the used car market need to sell many great cars at cheaper prices. CarMax already posted its official warning of a potential "hit to profit-sharing revenue" due to inflationary impact to its partners, before last Christmas. "While affordability of used cars remains the challenge for consumers, pricing improved during the quarter," Enrique Mayor-Mora, executive vice president and CFO admitted.

It was only a smaller division of CarMax Auto Finance, which managed to get a 19% better income due to "a lower provision for loan losses" and an increase in average managed receivables. Yet, this was rather news from the side business, which was clearly not enough to be optimistic. The company added that it is now focused on enhancing its omni-channel experience and leveraging data science and automation. Carmax said it delivered "strong retail and wholesale" graphic processors, which helped to increase "used saleable inventory units" more than 10%, but used total inventory units was unchanged despite innovations. The company seeks to achieve efficiency improvements in its core operations, believing that they "are well-positioned to drive growth as the market turns", according to Enrique Mayor-Mora. This may be useful to strengthen competitiveness in better times for the segment. Yet, the current challenges are too heavy to be ignored by market crowds.

16.06.2022
Not Every Tech Stocks are Equally Strong: SAP

SAP stocks have lost 30% since the beginning of 2022. The German tech company develops enterprise software and solutions to manage business operations. For example, one of its services can be used  to manage all business travel financial activities and related spending. In other words, it is quite a routine company with  a stable and strong cash flow. Once SAP software is installed on a corporate level it is hard to do without it as it is deeply integrated into the business core processes. Moreover, SAP is restructuring its business model around its subscription base and this will allow for cash flows to be even more predictable and balanced through the financial year. Such a model is in favourable to Wall Streel investors.

The war in Ukraine has a 300-million-euro negative effect on SAP business, and it is only a marginal 1% of the overall revenue base for the company, while its dominance in the ERP segment is secure. The revenues added 11% year-on-year to 7.08 euros in Q1 2022. The revenues grew by 6% in  Q4 2021.

The company has made some successful M&A deals, acquiring Qualtrics, a cloud-based subscription software platform, that delivered +48% revenue in Q1 2022. This company had a gross margin above 90% in 2021 while SAP’s gross margin was at 70% for the same year.

SAP management promised to triple its cloud-based business by 2025, and boost revenues to 22 billion euros, while operational profit is forecasted to grow by 40% from the current 8.4 billion euros. This is a very extensive growth for the company that has a high P/E ratio at 17. The company may not perform very high growth rates as its younger tech sector peers, but it may certainly recover to new all-time highs in the long-term perspective. However, the sector may require several quarters to recover, and the recovery would be headed by such reliable companies as SAP with a low risk profile.

15.09.2022
Safe Haven Assets for Long-Term Investments: Broadcom

Broadcom is an American semiconductor and infrastructure software development company. Soon it is expected to close a merger deal with VMware, a cloud computing and visualization company, that will open new cross-sales opportunities for Broadcom to boost its revenues. Broadcom stocks are now 25% off their peak values.

According to the Q3 FY 2022 financial report that ended July 31, consolidated revenues grew by 25% year-over-year to $8.46 billion, and EPS went up by 40% to $9.73 per share. The semiconductors segment, that added 32% year-over-year, was the primary driver for the company’s profit. The company’s free cash flows (FCF) topped $4.3 billion, allowing it to spend $1.7 billion on dividends and 1.5 billion on the shares repurchase program. The company is planning to continue spending at least 50% of FCF on dividends that added 43% every year on average since 2016. 

According to the Q4 FY 2022 forward guidance, the company is expecting its revenues to go up by 20% year-over-year to $8.9 billion and for EDITDA to go up by 25% to $5.6 billion. Broadcom has great experience in expanding its product portfolio by M&A operations, and apparently it will continue on this way. The company is also expected to benefit greatly from the $52.7 billion CHIPS bill in the United States.


12.05.2022
Perspective ETFs in the ESG energy segment: Invesco Global Clean Energy Portfolio ETF

This ETF invests in green energy ventures. The pandemic led to a 300% increase of its share price. But since the beginning of 2022 they have lost 30%, twice as much as the S&P 500 SPY ETF. The net capital which has outflown from the Fund has reached $31.5 billion over the last 12 months, while the major outflow was recorded in December 2021. However, its shares are still seen to be overbought as P/E multiplier is at 24 that is well above the average of 20 for the EFT’s that are linked to the S&P 500, while the dividend yields are above PBD’s numbers.

Inflation in the United States is rising negatively affecting all shares with a high P/E ratio. So, we may expect a further decline of the PBD share price and other similar assets that cannot be protected from rising risks. Traditional energies are looking more attractive on this background and could be a perfect hedge asset amidst geopolitical uncertainties. 

11.08.2022
Perspective Peers of Ethereum: Avalanche

Avalanche is ranked by Coinmarketcap at the 12th position by market cap with $7.8 billion, which is 4% less than Ethereum’s market cap. AVAX prices dropped by 82% of its peak values, allowing investors to buy it at early 2021 prices. Avalanche’s infrastructure consists of three logically isolated networks, each of these with their own processing, validators, and own set of rules.

This platform is often compared to the existing internet web infrastructure with core connection protocols like HTTP, surrounded by a huge number of networks to their apps. Avalanche allow for the creation of public and private systems as a blockchain or DAG (Directed Acyclic Graph) and for the use of different virtual machines for apps, including EVM engine (Ethereum Virtual Machine) that allows Enthereum network programs to be developed.

Avalanche includes C-chain to create smart contracts that are processed on an advanced EVM engine, P-Chain that coordinates validators that process transactions and also allows for the creation and management of new subnetworks, and X-Chain which is a directed acyclic graph regulating issuance and trade of cryptoassets. DAG systems record new transactions on top of the old ones, allowing for processing speed to be increased and for capacity substantially. It is quite different to other blockchains, where transactions are compiled in blocks in order to be processed.

The advantage of Avalanche is that it provides anyone with the opportunity to create his or her own isolated blockchain with its own set of parameters, including access to apps and the programming language with which it will work. Every subnetwork can process around 4,500 transactions per second compared to 14 processed by the Ethereum network.

Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Shorting Gold from Solid Resistance

Gold prices dazzled the market with an unbearable shine last week after prices leapt by 4.4% to $2431 per troy ounce. Following the attainment of new all-time highs, they retreated to $2324. The resistance at $2400-2500 per ounce remains formidable and unyielding. A breakthrough in this zone seems highly improbable. The $2400-2450 range appears secure for initiating short trades. My target is $2200-2220 by the end of April. I will set the stop-loss at $2600 per ounce.

3626
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
LRC is Struggling to Recover Towards $0.300

Loopring (LRC) saw a decline of 1.6% this week, trading at $0.248. This movement can be interpreted as a consolidation phase following a significant 39% drop over the weekend, which occurred amidst heightened military tensions in the Middle East. Despite the consolidation, prices are currently below the support of an ascending channel that has remained intact since October 20, 2023.

For the fifth consecutive day, the altcoin has been closing below this critical support level. To resume its upward trajectory, LRC would need to stage a recovery of at least 50%, reaching $0.300. While such a recovery is plausible, any further delays in reclaiming this level could lead to a deterioration in prices, potentially pushing LRC below $0.200.

Such a scenario would be detrimental for the altcoin, as it would signify a breakdown from its established channel and could trigger significant selling pressure.

4048
The Best Performing US Bank in the Earnings Week: Morgan Stanley

Morgan Stanley (MS) is one of the best performers among the largely drowning stocks of US banks during this earnings season. Indeed, it managed to hold nearly 2.5% of intraday gains at the regular session of April 16, when its Q1 report came out. Yet, the initial surge in share price reached a 4% of height soon after the opening bell, accompanied by fresh profit taking, as no enthusiastic buyers were seen near these slightly elevated levels. Technically, the two latest candlesticks on MS daily charts turned black despite initial price gaps, which is not a positive sign even for the short-term.

A chance for testing multi-month resistance at nearly $95 per share is still here, because Morgan Stanley showed no essential weaknesses in its own forecasts for the rest of the year, unlike other monster financial institutions including JPMorgan Chase and Wells Fargo, which noted last Friday that their interest payments were below expectations, as the whole banking industry needed to be ready to future Federal Reserve's rate cuts. Rising uncertainty over the central bank's outlook for the borrowing costs prompted the benchmark 10-year public bond yields to soar above 4.65% this week, which is good for interest income, but understates the value of the banking balance sheets, based on the same kind of U.S. bonds which the banks had to acquire for safe haven purposes over the years. Now these bonds rather became the source of financial rigidity, or one may call it awkwardness, leading to the lack of free cash the banks may use for their lending business and investment purposes.

As other Wall Street banking pillars, Morgan Stanley beats consensus estimates in terms of its incredible past performance. Higher investment banking segment helped a lot, which also took place in the case of Goldman Sachs, as another rather positive example. "We saw building momentum in investment banking, both in our M&A and underwriting pipelines across corporate and financial sponsor clients," Morgan Stanley CEO Ted Pick commented, adding that a "multi-year M&A cycle" is to be launched now, and this period may last 3 to 5 years. Geopolitical risks may even create incentive for more deals, he said, when businesses are shifting their international footprint partly because of the two major conflicts. Morgan Stanley also noted it is still bullish on the U.S. economy.

Q1 2024 was the best quarter for MS since April 2022, as the banking group announced its EPS (equity per share) of $2.02 vs consensus estimates of $1.66. A more than 20% surplus compared to average forecasts, yet a rising wave on charts is very modest. Logically, the situation around other banking stocks with worse reported (and especially forecasted) numbers may be even less enjoyable for the bullish camp. We clearly understand that other large banks are usually more dependent on their customers' well-being, rather than investment projects. This is why the Bank of America lost 3.5% on the same day, despite its EPS was also more than 9% above consensus estimates, yet this has not bailed it out to escape from price falling. Competition in high yield from private credit and leveraged loan markets were marked even in the conference call by Morgan Stanley.

The first quarter was good for most U.S. banks, yet the future prospects scared the crowds of investors. If so, they are ready to move down on the stocks of many other big banks and are ready to be no more than just patient in the best cases like Morgan Stanley and Goldman Sachs. There is a great distance between the road of tolerance to potential headwinds and the road of enthusiastic buying on the hot heels of earnings reports. So, other segments seem preferable compared to any banking stocks.

4564
Johnson & Johnson Failed To Reverse the Downtrend

Johnson and Johnson (JNJ) was the first member of the health consumer staples club to report in the spring on Wall Street. As a large producer of essential hygiene products, personal care items and services, it could reap the benefits of its unique positioning on markets as most people are addictive in their nature to the same kind of skin health brands and baby medications. JNJ is also one of the world leaders in providing prescription and over-the-counter drugs, surgical equipment and orthopaedic implants, which are difficult to be replaced by anything else. Nevertheless, the stock lost 2.15% of their value on April 16. As a result, a smoothly descending channel on monthly charts since the beginning of 2023 still stands intact.

Nominally, the Q1 growth numbers were even better than expected, with EPS (equity per share) coming out at $2.71 vs $2.64 of consensus projections. Yet, there is almost no increase in profit in absolute terms over the past two years, which means the medtech giant is earning less if adjusted for inflation effects. Therefore, even though J&J performance in the segment of innovative medicine could be called impressive, as it contributed to 63.5% of the company's sales amounting to $13.56 billion against preliminary estimates of $13.47 billion, most large investment houses were not satisfied. Some of them just preferred to moderately cut their mid-term targets for the company's price, in the range of $5 to $10 per share to the current levels around $145, citing a lacklustre in forward guidance parameters for the rest of 2024, foreign exchange headwinds (a reason why international sales declined by 0.3% Y0Y) and other factors like a potential loss of exclusivity for Stelara drug brand, which was designed to treat psoriasis, related arthritis and ulcerative colitis.

Johnson & Johnson sees its adjusted operational EPS to range between $10.60 and $10.75 for 2024, with "Innovative Medicine sales growth is expected to be stronger in the first half of the year". Does it mean that the second part of 2024 would experience a slowdown? Again, the Vision Care business of the giant has narrowed due to "changes in distributor inventory". JNJ's CEOs commented on the strategic acquisition of Shockwave Medical and Ambrx to strengthen the company's cardiovascular and oncology portfolios, which could be important but still questionable from the point of view of future financial return. The session of questions and answers during the conference call also included the multiple myeloma franchises and litigation related to some patents, while the company's representatives affirmed confidence in their solid position. The company's future prospect looks rather optimistic, yet the share price dynamics based on mentioned challenges suggests that prematurely buying of JNJ stock at any levels well above the lows of April 2020 may be unreasonable, if only no fresh fundamental drivers appear.

4100
183

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors